Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Walter

Showing results (641-650 of 737) with videos related to

Pageof 74
Sort By:
Journal of Medical Internet Research|September 16, 2017
Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized TrialMarkus Wallwiener, Lina Matthies, Elisabeth Simoes, et al.
Vaccine|January 22, 2019
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adultsChristopher W Woods, Ana M Sanchez, Geeta K Swamy, et al.
Leukemia & Lymphoma|May 7, 2024
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation studyFarhad Ravandi, Marion Subklewe, Roland B Walter, et al.
Blood|July 27, 2018
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AMLAmir T Fathi, Harry P Erba, Jeffrey E Lancet, et al.
British Journal of Haematology|September 12, 2014
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patientsJohn B Porter, Patrick B Walter, Lynne D Neumayr, et al.
Leukemia|July 13, 2026
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Mary-Elizabeth M Percival, et al.
Journal of Medical Internet Research|January 23, 2019
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability StudyLina Maria Matthies, Florin-Andrei Taran, Lucia Keilmann, et al.
Transplantation and Cellular Therapy|January 2, 2026
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence from Machine Learning and Regression ModelsAshish Narayan Masurekar, Kelly M Burkett, Arya Rahgozar, et al.
Cancer|March 19, 2016
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignanciesGautam Borthakur, Leslie Popplewell, Michael Boyiadzis, et al.
Blood|December 3, 2017
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemiaEytan M Stein, Roland B Walter, Harry P Erba, et al.
Pageof 74

Showing results (641-650 of 737) with videos related to

Sort By:
Pageof 74
Journal of Medical Internet Research|September 16, 2017
Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized TrialMarkus Wallwiener, Lina Matthies, Elisabeth Simoes, et al.
Vaccine|January 22, 2019
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adultsChristopher W Woods, Ana M Sanchez, Geeta K Swamy, et al.
Leukemia & Lymphoma|May 7, 2024
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation studyFarhad Ravandi, Marion Subklewe, Roland B Walter, et al.
Blood|July 27, 2018
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AMLAmir T Fathi, Harry P Erba, Jeffrey E Lancet, et al.
British Journal of Haematology|September 12, 2014
Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patientsJohn B Porter, Patrick B Walter, Lynne D Neumayr, et al.
Leukemia|July 13, 2026
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Mary-Elizabeth M Percival, et al.
Journal of Medical Internet Research|January 23, 2019
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability StudyLina Maria Matthies, Florin-Andrei Taran, Lucia Keilmann, et al.
Transplantation and Cellular Therapy|January 2, 2026
Defining the Limits of Pre-Transplant Risk Prediction in AML: Evidence from Machine Learning and Regression ModelsAshish Narayan Masurekar, Kelly M Burkett, Arya Rahgozar, et al.
Cancer|March 19, 2016
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignanciesGautam Borthakur, Leslie Popplewell, Michael Boyiadzis, et al.
Blood|December 3, 2017
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemiaEytan M Stein, Roland B Walter, Harry P Erba, et al.
Pageof 74